Two-stage treatment of non-small cell lung cancer (NSCLC) in patients with severe coronary heart disease.

A. Reshetov (Saint-Petersburg, Russian Federation), G. Nikolaev (Saint-Petersburg, Russian Federation), A. Elkin (Saint-Petersburg, Russian Federation), S. Snepanov (Saint-Petersburg, Russian Federation), D. Ermakov (Saint-Petersburg, Russian Federation), V. Klimenko (Saint-Petersburg, Russian Federation)

Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Session: Symptoms, risks, complications and palliative care in thoracic oncology
Session type: Thematic Poster
Number: 4662
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Reshetov (Saint-Petersburg, Russian Federation), G. Nikolaev (Saint-Petersburg, Russian Federation), A. Elkin (Saint-Petersburg, Russian Federation), S. Snepanov (Saint-Petersburg, Russian Federation), D. Ermakov (Saint-Petersburg, Russian Federation), V. Klimenko (Saint-Petersburg, Russian Federation). Two-stage treatment of non-small cell lung cancer (NSCLC) in patients with severe coronary heart disease.. 4662

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: